ADD-ASPIRIN trial: Principal Investigator for Oesophago-Gastric cohort

Activity: Other activity typesOther

Description

A phase III, double-blind, placebo-controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours
Period25 Oct 201710 Mar 2023
Held atUniversity College London, United Kingdom
Degree of RecognitionInternational